Le Lézard
Classified in: Health, Science and technology, Business
Subjects: CON, OTC

InnerScope Hearing Technologies, Inc. Retains Barwicki Investor Relations to Provide Global Investor Relations Program


ROSEVILLE, California, January 5, 2018 /PRNewswire/ --

InnerScope Hearing Technologies Inc. (OTCQB: INND) announced that it has retained Barwicki Investor Relations, a New York-based investor relations firm, to expand the Company's strategic investor relations program. Barwicki Investor Relations is run by Andrew Barwicki, a seasoned veteran with 24 years of marketing and investor relations experience.

Matthew Moore, CEO of InnerScope Hearing Technologies, said, "After careful consideration, Barwicki Investor Relations Inc., with their established relationships among institutional investors, combined with their extensive databases and pro-active investor relations program, is the perfect partner for InnerScope. We are pleased to partner with Barwicki Investor Relations to assist us in effectively communicating our strategy and objectives to the investment community. This partnership represents an important step for us in the fulfillment of our goal of positively impacting the health and well-being of as many people as possible. We expect to develop a strong, on-going relationship with this proven Investor Relations firm, and look forward to growing our presence within the investment community as we continue our Company's development."

Barwicki Investor Relations will provide the investment community with information and updates about InnerScope through the distribution of INND Fact Sheets, scheduling road shows, conference calls, and one-on-one meetings with institutional investors and broker dealers throughout the United States. The investor relations program will also target retail investors and investors within our specific industry.

Andrew Barwicki, President of Barwicki Investor Relations, Inc., said, "I welcome this opportunity to work with InnerScope, and I am very excited to help the investment community better understand their compelling and differentiated strategy and growth opportunities. We expect interest from the financial community will continue to grow and we are delighted to be part of the InnerScope team. Working with a company within the health sector that can positively impact 1.2 billion people that have hearing loss is a unique opportunity that I am enthusiastic about."

About Barwicki Investor Relations, Inc. 

Barwicki Investor Relations is a full service investor relations firm, representing growth-oriented companies to the investment community. Investor relations services include financial community and media relations, editorial services and interactive communications, as well as administrative, consulting and advisory services. Barwicki Investor Relations will ensure that money, fund, and portfolio managers, financial analysts, brokers and individual investors receive a constant flow of information and updates. Additional information available at http://www.barwicki.com.

About InnerScope Hearing Technologies (INND): 

InnerScope Hearing Technologies  is a technology driven company with highly scalable B2B and B2C solutions. The Company offers a B2B SaaS based Patient Management System (PMS) software program, designed to improve operations and communication with patients. INND also offers a Buying Group experience for audiology practice, enabling owners to lower product costs and increase their margins. INND will also compete in the DTC (Direct-to-Consumer) markets with its own line of "Hearables", and "Wearables" and revolutionary APPs on the iOS and Android markets.

InnerScope intends on opening, operating and expanding a chain of audiological and retail hearing device clinics.  INND's seasoned team of professionals, with collectively over 200+ years of experience in the hearing aid industry, including successful operations in hearing aid manufacturing and retail store management. Our team has the knowledge, relationships, and the experience to quickly deploy new products and software to serve approximately 1.2 billion people around the globe that are suffering with 25 db or greater hearing loss. For more information, please visit http://www.innd.com .

Safe Harbor 

This presentation contains forward-looking statements which relate to future events or InnerScope Hearing Technologies future performance or financial condition. Any statements that are not statements of historical fact (including statements containing the words "believes," "should," "plans," "anticipates," "expects," "estimates" and similar expressions) should also be considered to be forward-looking statements. These forward-looking statements are not guarantees of future performance, condition or results and involve a number of risks and uncertainties. Actual results may differ materially from those in the forward-looking statements as result of a number of factors, including those described from time to time in InnerScope Hearing Technologies filings with the Securities and Exchange Commission. InnerScope Hearing Technologies undertakes no duty to update any forward-looking statements made herein.

Contact:

Investor Relations Contact
Andrew Barwicki
+516-662-9461
[email protected]  

InnerScope Hearing Technologies, Inc. 
Matthew Moore
[email protected]
+916-218-4100

http://www.innd.com

SOURCE InnerScope Hearing Technologies, Inc.


These press releases may also interest you

at 13:20
Garrett Smith, Founder and CEO of Community Capital Technology Inc. ("Community Capital"), will be attending the Milken Institute Global Conference ("MI Global") May 5-8, 2024 in Los Angeles. The event brings together global executives and...

at 13:16
Quarterhill Inc. ("Quarterhill" or the "Company") , a leading provider of tolling and enforcement solutions in the Intelligent Transportation System ("ITS")...

at 12:25
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing novel solutions that treat urothelial and specialty cancers, today highlights the results of a sub-analysis from the first and largest real-world patient cohort review...

at 09:05
Smart Meter, the leading supplier of Cellular Remote Patient Monitoring (RPM)tm solutions, has introduced a new version of the iGlucose, its patented cellular-connected glucose meter used by over 200,000 people with diabetes since 2019. The...

at 09:05
F5 announced that it has been singled out as a visionary in API security for its F5 Distributed Cloud Web App and API Protection (WAAP) in Enterprise Management Associates' Vendor Vision 2024 report. The report highlights "must see" security...

at 08:05
GE HealthCare today unveiled SIGNA MAGNUS, an FDA 510(k) pending head-only magnetic resonance (MR) scanner designed to explore advancements in neuroscience, which have been restricted by the performance limitations of conventional whole-body MR...



News published on and distributed by: